Results For " "

How Long Does It Take to See Results From Radiation Therapy for Breast Cancer? Blog Post

Pope Leo XIV’s Lung Cancer Diagnosis: Expert Insights Blog Post

W. Taylor Rowlett, M.D.

Tennessee Oncology Physician Contributes to Landmark Longevity Research Blog Post

Grace Meier, PA-C

Lauren Connor, M.D.

Tennessee Advanced Plastic Surgery – Smyrna

Metastatic Prostate Cancer Treatment Options Blog Post

Preston Palm, M.D.

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

Phase 3 Randomized Study Comparing JNJ-79635322 in Combination with Pomalidomide, versus Belanatamab Mafodotin, Pomalidomide and Dexamethasone (BPd) or Daratumumab, Carfilzomib and Dexamethasone (DKd) in Participants with Relapsed or Refractory Multiple Myeloma

A Phase 3, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants with Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

A Phase 2, Multicohort, Open-Label Study of Rina-S in Participants with Advanced Gastrointestinal (GI) Cancers

A Phase 1 Study of PARG inhibitor FORX-428 in Patients with Advanced Solid Tumors with BRCA1/2 Mutations or other DDR deficiencies or high replication stress

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

A Phase 1a/1b multicenter, open-label dose escalation/expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor activity of PLN-101095 as monotherapy and in combination with pembrolizumab in adult participants with advanced or metastatic solid tumors who have disease progression while on an immune checkpoint inhibitor (FORTIFY)

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

GU Location Page

GU Katy Beckermann Page

GU David Slosky Page

GU John Phillips Page

Clarksville Clinic – The Surgical Clinic

GU Testicular Cancer Page

GU Kidney Cancer Page

GU Bladder Cancer Page

GU Prostate Cancer Page

GU Contact Page

GU Our Team Page

GU Cancer Services Page

GU Center of Excellence Page

Hanna Yager, FNP-BC

Carly Williams, AGCNS-BC

Claire Tomlinson, PA-C

M. Hannah Thiele, FNP-C

Leah Partlow, MSN, APRN, FNP-BC

Mechele Neal, MSN, RN, APRN, FNP-BC

Erica Long, PA-C

Joni Lee, PA-C

Meredith Heppler, ACNP-BC

Kate Glomski, PA-C

Caleb Fresh, DNP, ACNP-BC

TJ Cantrell, FNP

Billy Cameron, ACNP-BC

Luke Boren, PA-C

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

GU care Search Page Page

Tennessee Oncology Achieves FACT Community IEC Accreditation Blog Post

Hayden Byrd, M.D.

Adrienne N. Christopher, M.D.

Vijal Parikh, M.D.

Aileen Greenberg, MSN, APRN, FNP-BC, FNP-C

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Tennessee Advanced Plastic Surgery – Nashville

Columbia Vein Centre – The Surgical Clinic

Enjoli Gupton, FNP-C

Institutional Biosafety Committee Meeting Minutes Page

Tennessee Oncology Opens New State-of-the-Art Tullahoma Medical Center Blog Post

Tullahoma Medical Center – Imaging

What Is Lung Cancer? Symptoms, Risk Factors, Types, and Treatment Blog Post

J. Alan Przybyla, M.D.

Adam Hubler, M.D.

S. Patrick Bliven, M.D.

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY OF MEVROMETOSTAT (PF-06821497) WITH ENZALUTAMIDE IN METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER (MEVPRO-3)

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Leslie Sullins, NP-C

Therese Shank, MSN, APRN, AGACNP-BC

Cancer Fund Page

A Study to Learn About the Study Medicine Called PF-08046054/?SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

A Study of TAK-505 in Adults With Solid Tumors

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Darrel T. Hull, AANP-FNP-C

Naimisha Marneni, M.D.

Lauren Kropp, M.D.

Men’s Health Month: The Cancer Screenings and Healthy Habits Every Man Should Know Blog Post

Christopher Wright, FNP-C

Executing a Major Renovation Around Cancer Care: How Tennessee Oncology is Giving Its Downtown Chattanooga Office a Major Facelift Blog Post

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Carolyn Lowery, MSN, APRN, FNP-BC

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY

A Phase 1 Study of JNJ-87189401 (PSMA-CD28 Bispecific Antibody) Combined with JNJ-78278343 (KLK2-CD3 Bispecific Antibody) for Advanced Prostate Cancer

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

Phase III, Multi-centre, Ransomised Controlled Study of Sonesitatug vedotin in Combination with Fluoropyrimidine with or without Rilvegostomig in First-line Claudin 18.2-positive HER2-negative Advanced/Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or in Combination with Ipilimumab in Participants with First-Line Advanced or Unresectable Hepatocelluar Carcinoma (HCC)

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Women’s Health Month: Four Essential Cancer Screenings Every Woman Should Know Blog Post

Breast Surgery at the Women’s Health Center Page

Radiation Oncology at the Women’s Health Center Page

Gynecologic Oncology at the Women’s Health Center Page

Medical Oncology at the Women’s Health Center Page

Madison Dykes, PA-C

Auchaia Farley, PA-C

Mary E. Sims, MSN, APRN, FNP-C

Alyssa Woodin, MSN, APRN, FNP-BC

Callie Fluhrer, MSN, FNP-BC

Kristen Allen, DNP, FNP-BC

Community Oncology Alliance Welcomes Dr. Johnetta Blakely as Chief Medical Officer Blog Post

Patrick C. Yu, M.D.

Patrick S. Wolf, M.D., FACS

Todd H. Wilkens, M.D., FACS

John Valentine, M.D.

Mark W. Shelton, M.D.

Adam A. Richter, M.D., FACS, RPVI

Drew H. Reynolds, M.D.

William H. Polk, M.D.

D. Davidson Oxley, M.D., FACS

Stephen Owen, M.D.

Elizabeth F. Nelson, M.D., RPVI

Chad M. Moss, M.D., FACS

Ethan Montemayor, M.D.

Willie V. Melvin III, M.D., FACS

Clinton A. Marlar, M.D.

George B. Lynch, M.D., FACS

Jeffrey Levine, M.D., FACS

E. Dwayne Lett, M.D.

Brian Kendrick, M.D.

Mark S. Hinson, M.D., FACS

Bassam Helou, M.D.

James Thomas Griscom III, M.D.

Tiffany Gesang, M.D.

Alex B. Fruin, M.D.

JimBob Faulk, M.D., FACS, RPVI

Gretchen Edwards, M.D., MPH

Patrick T. Davis, M.D., FACS, FASMBS

Mariana Chavez, M.D., FACS

Zachary Callahan, M.D.

Tod Bushman, DPM

Timothy W. Bush, DPM

Christopher M. Braxton, M.D.

John A. Boskind, M.D., FACS

Roger A. Bonau, M.D., FACS

Julia Boll, M.D., FACS, RPVI

Thomas Beazley, M.D.

Ron Roberts, M.D.

Billy J. Kim, M.D., FACS

Allen P. Lee, M.D., FACS, RPVI

M. Caroline Nally, M.D., FACS, RPVI

Marc E. Rosen, D.O., FACOS

Joshua T. Taylor, M.D., FACS

K. Tyson Thomas, M.D., FACS

Mt. Juliet Clinic – Vein Centre

Downtown Nashville Clinic – Vein Centre

Nashville Vascular Procedure Center – The Surgical Clinic

Mt. Juliet Vascular Procedure Center – The Surgical Clinic

Columbia Vascular Procedure Center – The Surgical Clinic

TSC Prosthetics Clinic

Mt. Juliet Clinic – The Lett Center

Lebanon Clinic – The Lett Center

Mt. Juliet Clinic – The Surgical Clinic

Southern Hills Clinic – The Surgical Clinic

Saint Thomas West Clinic – The Surgical Clinic

Rutherford Clinic – The Surgical Clinic

Skyline Clinic – The Surgical Clinic

Murfreesboro Clinic – The Surgical Clinic

Hendersonville Satellite Clinic – The Surgical Clinic

Hendersonville Clinic – The Surgical Clinic

Gallatin Clinic – The Surgical Clinic

Franklin Clinic – The Surgical Clinic

Foot & Ankle Specialists of Nashville – The Surgical Clinic

Downtown Nashville Clinic – The Surgical Clinic

Dickson Clinic – The Surgical Clinic

Cookeville Clinic – The Surgical Clinic

Columbia Clinic – The Surgical Clinic

Brentwood Clinic – The Surgical Clinic

Tennessee Oncology Breaks Ground on New Cancer Center in Murfreesboro Blog Post

Kidney Cancer: What You Need to Know Blog Post

Connie M. Hodges, MSN, APRN, FNP-C

Sarah Harris, FNP-C

Cellular Therapy Page

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

A Study of V940/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013) (INTerpath-13)

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 (HARMONi-7)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract (FORAGER-2)

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer (HARMONi-GI3)

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors (ARC-20)

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Colorectal Cancer: What You Need to Know About Screening, Symptoms, Prevention, and More Blog Post

Travis Scurlock, MSN, FNP-C

Tennessee Oncology Opens New Cancer Care Clinic in Lafayette Blog Post

Lafayette Clinic

Understanding Low-Dose Radiation Therapy (LDRT) for Chronic Pain and Inflammation Blog Post

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/PRO1184-001) (RAINFOL-01)

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Tennessee Oncology and OncoveryCare Expand Survivorship Care Blog Post

Understanding Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Dr. Mali Schneiter Blog Post

Mauriska Cash-Munroe, NP

Inclement Weather Updates: Closures for February 2, 2026 Blog Post

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/?INTerpath-009)

ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET (NETTER-3)

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-01)

Inclement Weather Updates: Closures and Delays for January 29, 2026 Blog Post

Inclement Weather Updates: Closures and Delays for January 28, 2026 Blog Post

Inclement Weather Updates: Closures and Delays for January 27, 2026 Blog Post

Inclement Weather Updates: Closures and Delays for January 26, 2026 Blog Post

All Things Cervical Cancer Awareness Month with Dr. Michael Stany Blog Post

Jaime Pesl, DNP, NP-C, AOCNP

Brittany Cannon, PA

Frank Kimsey, M.D., FACR

Tennessee Oncology Celebrates 50 Years of Patient Care Blog Post

Angela Fitzpatrick, MSN, APRN, FNP-BC

Jennifer Bagwell, MSN, APRN, AGPCNP-C

Andrew S. Camarata, M.D., MBA

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3 (FORAGER-1)

Mira Patel, D.O.

A Phase I/?II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (Lumi-NHL)

IKS014 in Advanced Solid Tumors That Express HER2

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (Morpheus-panBC)

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia (ALLight)

Tennessee Oncology Appoints Dr. John Phillips EVP for Radiation Oncology Centers Blog Post

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer (ReDiscover-2)

Ashley Lloyd, MSN, APRN, FNP-C

Kaylyn Banks, RN, MSN, FNP-C

Our First Year Providing Cancer Care in Johnson City Blog Post

Barbara Thompson, MSN, FNP-C

Yolanda Mabry, FNP-C, AANP

Stacy Perez, MSN, APRN, FNP-C

Brooke Pilkington, PA-C

Anahita Sharghy, MSN, FNP-C

Cynthia Krauss, FNP-C

Amber Reams, AG-ACNP

Amanda Morehouse, M.D.

Tennessee Oncology Opens Early-Phase Clinical Research Unit Blog Post

Elliston Place Plaza – Drug Development Unit

Let’s Talk About Sensation After Mastectomy Blog Post

Katie Geraldson, FNP-BC

Brian Grieb, M.D., Ph.D.

Constantine Logothetis, M.D.

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/?Refractory Diffuse Large B-Cell Lymphoma

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer (NeoCOAST-2)

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) (KLK2-comPAS)

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

No Surprises Act Page

Tennessee Oncology and Ascension Saint Thomas Launch Women’s Comprehensive Cancer Center at Midtown Blog Post

Hope Diaz, DNP, PC

Tennessee Oncology Breaks Ground on State-of-the-Art Medical Center in Tullahoma Blog Post

Low-Dose Radiotherapy for Osteoarthritis Page

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Caring for Cancer Patients is a Privilege Page

Pranav Santapuram, M.D.

Sean M. Parker, M.D.

Katherine Castle, M.D.

Moriah Forster, M.D.

Anna-Carson Rimer Uhelski, M.D.

Celebrating Our 2025 Leadership Academy Graduates Blog Post

Madelyn Miller, MSN, APRN, AGPCNP-BC, OCN

Greco-Hainsworth Centers for Research Page

Aleksandra Robertson, D.O.

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer (SUNRAY-02)

Study of Olverembatinib (HQP1351) in Patients With CP-CML (POLARIS-2)

Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors

Will Fleming, FNP-C

Elizabeth Sun Mee Bigger, M.D.

My Story Page

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer (EvoPAR-BR01)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR

Tennessee Oncology Begins Treating Patients at New Flagship Cancer Center in Nashville Blog Post

Ryan Whitaker, M.D., Ph.D.

Jackson Reynolds, M.D.

Elliston Place Plaza – Center for Blood Cancers

Elliston Place Plaza – Medical Oncology & Hematology

Tennessee Oncology Opens Third Cancer Care Clinic in East Tennessee Blog Post

APP Fellowship Page

Franklin – Proton Center – Medical Oncology

Tennessee Oncology and Ascension Saint Thomas Launch Cancer Fund to Support Patients Facing Barriers to Cancer Care Blog Post

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments (DREAMM-20)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

David Slosky, M.D.

Cancer Facts for Men Blog Post

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/?Refractory Mantle Cell Lymphoma

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

David Chism, M.D.

Alcoa Clinic

Tennessee Oncology Featured as a Health Hero in New Documentary Series Blog Post

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer (SUNRAY-01)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence (ELEGANT)

Saci-IO TNBC: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in PD-L1-negative Metastatic Triple Negative Breast Cancer (TNBC)

A Phase 1 Study of KTX-1001, an Oral, First-In-Class, Selective, and Potent MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma

Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (CAMMOUFLAGE Trial)

A Phase 1, Open-Label, Dose-Finding Study of BMS-986453, Dual Targeting BCMAxGPRC5D Chimeric Antigen Receptor T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma

MMRC HORIZON ONE: A PHASE II RANDOMIZED ADAPTIVE PLATFORM TRIAL EVALUATING NOVEL THERAPIES IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel versus Standard of Care Treatment as First-Line Therapy in Subjects with High-Risk Large B-Cell Lymphoma (ZUMA-23)

A Phase 1/2, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies

A randomized, open-label, phase 3 trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic Non-Small Cell Lung Cancer (NSCLC) and secondary resistance to Immune Checkpoint Inhibitor (ICI)- ARTEMIA study

A Phase III, Randomized, Double-Blind, Multicenter, Global Study of Rilvegostomig in Combination with Chemotherapy for First-line Treatment of Patients with Metastatic Non-squamous Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung03)

A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-8371 in Patients with Advanced Malignancies

Phase 1/2, Open-label, Multi-center Study of the Safety, Tolerability, and Efficacy of GIM-531 as a Single Agent and in Combination with Anti-PD-1 in Advanced Solid Tumors

First-in-Human, Open-Label, Phase 1/2 Dose-Escalation with Enrichment and Dose-Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of GIM-122 as a Single Agent in Adult Subjects with Advanced Solid Malignancies

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/?NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy (OrigAMI-3)

A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Megan Ward, MSN, FNP-C

Park Pharmacy Page

Mesha Mathis, PA-C

Tennessee Oncology Opens New Cancer Clinic in Morristown, Expanding Access to Care in Northeast Tennessee Blog Post

Esha Cannon, D.O

Tennessee Oncology Appoints Dr. Casey Chollet-Lipscomb as Chief Medical Officer Blog Post

Mt. Juliet Specialty Clinic

Tullahoma Medical Center – Radiation Oncology

Inclement Weather Updates: Closures and Delays 2/20 Blog Post

Inclement Weather Updates: Closures and Delays 2/19 Blog Post

Kristin Buss, PA-C, MPAS

Jennifer R. Green, M.D.

Mailien Reed Rogers, D.O.

Morristown Clinic

Brandie Haga, DNP, APRN, FNP-BC, AOCNP

Amy Boren, MSN, FNP-C

Angela Parrish, MSN, APRN, FNP

Katy Beckermann, M.D., Ph.D. • Director of Genitourinary Cancer Research

Inclement Weather Updates: Clinic Delays for January 13th, 2025 Blog Post

The Surgical Clinic Joins Tennessee Oncology Network to Enhance Patient Care Blog Post

Clarksville – Women’s Health Center

Brayden Fernandez, MSM, PA-C

Roxy Shortridge, FNP-BC

Julie K. Gilliam, RN, MSN, FNP-BC

Myra Blankenship, APRN, MSN, FNP-BC

Teresa J. Burnette Lord, M.D.

Jamal G. Maatouk, M.D.

Johnson City Clinic

Tennessee Oncology Expands Cancer Care with New Clinic in Johnson City Blog Post

Tennessee Oncology Partners with The Surgical Clinic to Improve Middle Tennesseans Access to World-Class Care Blog Post

Tennessee Oncology and Ascension Saint Thomas Health Revolutionizing Community-Based Blood Cancer Treatments for Middle Tennessee Patients Blog Post

Jennifer “Jennie” Harper, ACNP-BC, AOCNP

Tennessee Oncology Opens First Radiation Oncology Center in Lebanon Expanding Access to World-Class Cancer Care Blog Post

Zachary S. Mayo, M.D.

Lebanon Radiation Oncology

Xiaoxiao Zhang, MBA, MSN, AG-ACNP

Carl R. Willis, M.D.

Karl M. Rogers, M.D.

Michael P. Stany, M.D.

J. Cory Barnett, M.D.

Ashley Brinkley, MSN, WHNP-BC

Emily Bechtel, MSN, WHNP-BC

Jill Weida, FNP

Tennessee Oncology Expands Subspecialty Services By Adding Two Renowned Gynecological Oncologists Blog Post

Nashville Midtown – Women’s Health Center

Women’s Health Center Page

New Patients Page

Radiation Oncology Page

Patient Resources Page

Mali Schneiter, D.O., MBA

Kate Baker, M.D., MMHC

Tennessee Oncology Welcomes Nashville Breast Center Blog Post

Dayna Huntley, OTR/L, CLT

Jessica Baker, PA-C

Lynn ‘Be’ Alt, APN, FNP-C

Laura L. Lawson, M.D.

Eduardo C. Dias, M.D.

Nashville Midtown – Nashville Breast Center

Allie Arnette Smallwood, MSN, APRN, AG-ACNP

Ailish Garrett, ACNP-BC

Sydney Spurgeon, PA-C

Virginia Pittman, MSN, APRN, FNP-C

Monica Chamberlain, DNP, ACNP-BC

Heidi Bradley, RN, FNP-BC

Miranda Landis, AGNP

Jonathan Weatherly, DNP, FNP-C

Maria Wood, BA, BHS, MPAS, PA-C, DFAAPA

Dallas A. K. Wright, PA-C

Amanda Vantrease, MSN, ACNP-BC

Sabin Von Almen, MSN, NP-C

Tiffani Watson, MSN, AGACNP-BC, AOCNP

Michelle Trebilcock, MSN, APRN, FNP-BC

Breanna Tucker, MSN, APRN, FNP-BC, AOCNP

Susan M. Utley, MSN, RN, FNP-BC, AOCNP

Deborah Skojac, RN, MS, AOCN

Helen Smith, MSN, FNP-C

Jennifer Spry, PA-C

Kyle Roberts, PA-C

Jessica B. Scott, MSN, AGNP-C

Amber Shoulders, MSN, FNP-BC

Jessica Purdom, MSN, ACNP, AOCNP

Addi Quattlebaum, APRN, MSN, FNP-BC, ACHPN

Tiffany Richardson, PA-C

Sara Perry, MSN, ACNP-BC

Matt Porter-Million, NP-C

Yvette Parsley, MSN, FNP-BC

Cathy Perry, DNP, ANP-BC, VA-BC, CRNI

Ashley Olsen, MSM, PA-C

Mark Owen, DNP, APRN, AGACNP-BC, FNP-BC

Amity Cagle, MSN, FNP-C, AOCNP

Kaitlin Moran, MSN, APRN, FNP

Amelia Norman, MSN, WHNP-BC

Alia Nunn, MSN, ANP-BC, AOCNP

Casey Meeks, NP

Sheila Miller, PA-C

Jenny Lee Mink, MSN, FNP-BC

Amanda McKenzie, MSN, FNP-BC

Michelle McMillan, MSN, APRN, FNP-BC

Christine Massell, MSN, FNP-BC

Jillian McClintock, MSN, APRN, FNP-C

Amy Latham, MSN, FNP-C

Janell M. Lowe, MSN, AGACNP-BC, AOCNP

Constance Lydon, DNP, FNP-C

Chassity Jones, DNP, APRN, FNP-BC

Andrea Knox, MSN, AG-ACNP

Katie Marcucci, DMSc, PA-C, CPAAPA

Stephanie Huffman, MSN, RN, FNP-C

Lauren Hunt, MSN, FNP-C, BMT-CN

Katie Johnson, MSN, AGPCNP-BC, AOCNP

Emily Heymann, MSM, PA-C

Lori Hill, MSN, AGNP-C, OCN

Brooke Houston, MSN, FNP-C

Jordan Gulley, MSN, APRN, FNP-BC

Annie Harris, MSN, NP-C

Jennifer Hennick, FNP-C

Kelly B. Golden, MSN, APN, FNP-C

Kathryn Grant, MSN, ANP, AOCNP

Mary Grizzard, MSN, FNP

April S. Gatlin, MSN, NP-C, AOCNP

Roxy J. Gazaway, MSN, NP-C

Lisa Forte, MSN, ACNP-BC, AOCNP

Jessica Fosbinder, MSN, FNP-C

Jessica Fay, MSN, FNP-C

Allie Flinn, MSN, AG-ACNP-BC

Kelsey Ellis, MSN, FNP-C

Sara Erger, MSN, APRN, AGPCNP, AOCNP

Gregory Evans, MSN, APN, AGACNP-BC

Mandy Dye, MSN, APRN, FNP-C

Tamara (Tammy) Kay Easterly, MSN, FNP-BC

Ellen Ehleben, MSN, A-GNP, AOCNP

Charlsie DeLoach, FNP-C

Dana L. DeMoss, MSN, WHNP-C

Sarah Donaldson, MSN, APRN, FNP-C

Mary W. Darden, MSN, APN-BC, AOCNP

Amanda Davenport, MSN, FNP-C

Nicole Deline, MSN, APRN, FNP-BC, AOCNP

Jonathan Choe, MPH, MA, MPAS, PA-C

Chelsea Collins, MSN, AGPCNP-C

Breanna Byrd, MSN, FNP-C, AOCNP

Tina Carden, NP-C

Kyle Casey, MSN, APRN, AGNP-C, AOCNP

Elizabeth Bruno, DNP, APRN, FNP-C

Zachary Davis Burke, MSN, FNP-BC

Holly Bushart, MSN, ACNP-BC, AOCNP

Catherine R. Benson, MSN, AGACNP-BC, AOCNP

Lesley Camille Ballance, MSN, FNP-BC

Nick Barkemeyer, PA-C, MMS

Kaytlyn Barnes, MSN, APRN, NP-C

Cyndi Adair, MSN, ACNP-BC

Sloan Austin, MSN, APRN, FNP-C

Nataly Bailey, MSN, AGPCNP-BC

Austin Dove, M.D.

Emily Jenkins, M.D.

Sara Nunnery, M.D., M.S.C.I.

Park Pharmacy Page

Jeffery Russell, M.D., Ph.D., MBA

Wade Iams, M.D., M.S.C.I.

Tennessee Oncology Partners Through the McKay Institute with OncoveryCare to Raise $4.5M Seed Round from .406 Ventures Blog Post

Support Organizations Page

Tennessee Promotes Three Physicians into New Leadership Roles Blog Post

Nurse Residency Program Page

Tennessee Oncology Proton Center Treats 2000th Patient Blog Post

Tennessee Oncology Launches Rural Telehealth Program to Bridge Digital Divide for Middle Tennessee Cancer Patients Blog Post

David Cooper, M.D.

Gina Vaccaro, M.D.

Leukemia – Eosinophilic Blog Post

Leukemia – Chronic T-Cell Lymphocytic Blog Post

Leukemia – Chronic Myeloid – CML Blog Post

Leukemia – Chronic Lymphocytic – CLL Blog Post

Leukemia – B-cell Prolymphocytic Leukemia and Hairy Cell Leukemia Blog Post

Leukemia – Acute Myeloid – AML – Childhood Blog Post

Leukemia – Acute Myeloid – AML Blog Post

Leukemia – Acute Lymphocytic – ALL Blog Post

Leukemia – Acute Lymphoblastic – ALL – Childhood Blog Post

McKay Institute for Oncology Transformation and Penn Center for Cancer Care Innovation Unveil New Collaborative Relationship Blog Post

Sarcoma, Soft Tissue Blog Post

Sarcoma – Kaposi Blog Post

Diagnostic Scans Page

Multiple Myeloma Blog Post

Liver Cancer Blog Post

Lung Cancer Blog Post

Unknown Primary Blog Post

Uterine Cancer Blog Post

Thyroid Cancer Blog Post

Skin Cancer (Non-Melanoma) Blog Post

Stomach Cancer Blog Post

Pancreatic Cancer Blog Post

Parathyroid Cancer Blog Post

Neuroendocrine Tumor Blog Post

Ovarian Cancer Blog Post

Myelodysplastic Syndromes – MDS Blog Post

Lymphoma – Non-Hodgkin Blog Post

Esophageal Cancer Blog Post

Lymphoma – Hodgkin Blog Post

Meet the Future of Community Oncology at the 2024 Community Oncology Conference Blog Post

Leadership Team Page

Tennessee Oncology Inclement Weather Updates: Closures and Delays 1/18 Blog Post

Tennessee Oncology Inclement Weather Updates: Closures and Delays 1/19 Blog Post

Tennessee Oncology Inclement Weather Updates: Closures and Delays 1/17 Blog Post

Tennessee Oncology Inclement Weather Updates: Closures and Delays 1/16 Blog Post

John Zubkus, M.D.

Mark Womack, M.D.

Patrick Williams, M.D.

J. Taylor Whaley, M.D.

Charles Wendt, M.D.

Christopher A. Waynick, M.D.

Daniel V. Wakefield, M.D., MPH

Marcus M. Wagner, M.D.

Monica Verma, M.D.

Harsha Vardhana, M.D.

An L. Tran, M.D.

Jill R. Tichy, M.D.

Dana Thompson, M.D.

Gregory Sutton, M.D.

Scott M. Strickler, M.D.

Michael Stipanov, M.D.

Mark P. Sittig, M.D.

Dianna Shipley, M.D.

Kent Shih, M.D.

Gregg Shepard, M.D.

Brian Schlick, M.D.

Stephen M. Schleicher, M.D., MBA

Larry Schlabach, M.D.

Barton J. Sanders, M.D., M.S.

Nitesh Rana, M.D., M.S.

Tennessee Oncology Inclement Weather Updates: Closures and Delays Blog Post

John G. Phillips, M.D., MPH • Executive Vice President of Radiation Oncology Centers

James D. Peyton, M.D.

Nancy Peacock, M.D.

Rohit R. Patel, M.D.

Eleanor Marshall Osborne, M.D., M.S.

My T. Nguyen, M.D.

Sam Naguib, M.D.

Sumana Nagireddy, M.D.

Benjamin Rolland Nadeau, M.D.

Patrick Murphy, M.D.

Sandhya Mudumbi, M.D.

Joshua K. Mondschein, M.D., M.S.C.I

Rachel L. Mitchell, M.D.

Mark Messenger, M.D.

Joseph Merriman, M.D.

Julie Means-Powell, M.D.

Samyukta Mullangi, M.D., MBA

Jeremy S. McDuffie, M.D.

Emily C. McDuffee, D.O., Ph.D.

Laura McClure-Barnes, M.D.

Richard Lewis Martin III, M.D., M.P.H.

Yanjun Ma, M.D., Ph.D.

Susanna Awoyode, M.D., M.H.S.

HIV and AIDS-Related Cancer Blog Post

Head and Neck Cancer Blog Post

Gastrointestinal Stromal Tumor Blog Post

Search Results Page

Support Organizations Page

Patient Bill of Rights Page

Gallbladder Cancer Blog Post

Colorectal Cancer Blog Post

Cervical Cancer Blog Post

Breast Cancer Blog Post

Bone Cancer Blog Post

Brain Tumor Blog Post

Nashville State Community College, Tennessee Oncology Form Medical Assistant Certification Program Blog Post

Language Assistance Services Page

Contact Us Page

Discrimination is Against the Law Page

Aviso de Prácticas Privacidad Page

Notice of Privacy Practices Page

Pharmacy Resources Page

Our Pharmacists Page

Research & Innovation Page

William Liggett, M.D.

Brian Lee, M.D.

Michel E. Kuzur, M.D.

Sylvia L. Krueger, M.D.

Revathi Kollipara, M.D.

Mathew Joseph, M.D.

Ryan T. Jones, M.D., MBA

Romany Johnpulle, M.D.

Derek Holland, M.D.

Brian Hemphill, M.D.

Bradley Harrison, M.D.

F. Anthony Greco, M.D.

James Gray, M.D.

Matt Graham, M.D.

Victor Gian, M.D.

Jeffrey Mathew Friedman, M.D., Ph.D

John Fortney, M.D.

Ian Flinn, M.D., Ph.D.

Nnamdi Eze, M.D.

Chase Escott, M.D., DABR

Jack Erter, M.D.

Habib Doss, M.D.

R. Dixon Dorand, Jr., M.D., Ph.D

William Donnellan, M.D.

Tru-Khang Dinh, M.D., M.S.

Natalie Dickson, M.D., MMHC, FACP • President, Chief Executive Officer

Varun Dhulipala, M.D.

Davey B. Daniel, M.D.

Support Services Page

Radiation Oncology Page

Ryan K. Cleary, M.D.

Casey Chollet-Lipscomb, M.D. • Chief Medical Officer

Ishita Chen, M.D., Ph.D.

Ryan Carr, M.D.

Johann Brandes, M.D.

Maribeth Bosshardt, M.D.

Johnetta Blakely, M.D., M.S., MMHC

Jia Bi, M.D.

Jesús Berdeja, M.D.

Todd Bauer, M.D.

Kirk Barnes, M.D.

Edward Arrowsmith, M.D. • Executive Vice President of Therapeutics

Bertrand Anz III, M.D.

Chirag J. Amin, M.D.

Olaide Ajayi, M.D.

Tamjeed Ahmed, M.D., M.S.

Tullahoma Medical Center – Medical Oncology

Saint Thomas West Imaging Alliance Clinic

Springfield Clinic

Spring Hill Clinic

Smyrna Radiation Oncology

Smyrna Clinic

Primary Services Page

Smithville Clinic

Shelbyville Clinic

Ringgold – North Georgia Radiation Oncology

Ringgold – North Georgia Medical Oncology

Nashville – Saint Thomas Midtown Radiation Oncology

Nashville – Saint Thomas Midtown Clinic

Nashville – Southern Hills Clinic

Nashville – Skyline Radiation Oncology

Nashville – Skyline Clinic

Elliston Place Plaza – Imaging

Nashville – Centennial Radiation Oncology

Nashville – Saint Thomas West Radiation Oncology

Nashville – Saint Thomas West Clinic

Murfreesboro – Tennessee PET Scan Center

Murfreesboro – Rutherford Radiation Oncology

Murfreesboro Clinic

McMinnville Clinic

Lebanon PET Scan Center

Lebanon Clinic

Lawrenceburg Clinic

Hixson – North Park Memorial

Hermitage – Summit Radiation Oncology

Mt. Juliet Clinic

Hendersonville Clinic

Gallatin Radiation Oncology

Gallatin Clinic

Franklin – Proton Center – Radiation Oncology

Franklin PET Scan Center

Franklin Clinic

Dickson Radiation Oncology

Dickson Clinic

Dalton – N.W. Georgia Hematology & Oncology

Cookeville Clinic

Columbia Clinic

Cleveland Regional Cancer Center

Cleveland Clinic

Clarksville Clinic

Chattanooga – Parkridge Radiation Oncology

Chattanooga – Memorial Radiation Oncology

Chattanooga – Memorial Plaza

Chattanooga – Medical Park II

Chattanooga – Erlanger Radiation Oncology

Chattanooga – Erlanger East Radiation Oncology

Chattanooga – East

Chattanooga – Downtown

Terms and Conditions Page

Location Card Page

Nashville State Community College, Tennessee Oncology Form Medical Assistant Certification Program Blog Post

Provider Card Page

Providers (GD) Page

Michael T. Byrne, D.O., FACP

Jonathan Abbas, M.D.

Chattanooga PET and Imaging Center

Athens Regional Cancer Center

Location (GD) Page

Trials API Test Page

Proton Center Page

About TNO Page

Tennessee Oncology Launches the Greco-Hainsworth Tennessee Oncology Centers for Research and Appoints Dr. Ian Flinn as Chief Scientific Officer Blog Post

Tennessee Oncology Launches McKay Institute for Oncology Transformation Blog Post

Caring for Cancer Patients is a Privilege – Original Page

The McKay Institute Page

Statement from Dr. Natalie Dickson, President, Chief Strategy Officer, Tennessee Oncology Blog Post

Tennessee Oncology Building New Flagship Cancer Center in Nashville Blog Post

Examining Colorectal and Cervical Cancer Care in Appalachia : A Review of Barriers and Interventions to Cancer Screening, Genetic Services, and Continuity of Care Blog Post

Tennessee Oncology Recognized as the State’s First Blue Distinction Center for Cancer Care Blog Post

Tennessee Oncology adds Proton Therapy Services Blog Post

Dr Stephen Schleicher: Rural Patient Care Access Is a Top Priority for Community Oncology Blog Post

The physical and mental benefits of exercise during chemo treatments Blog Post

Allergies and Natural Ways to Approach Them Blog Post

Discover Tomorrow at the 2023 Community Oncology Conference Blog Post

Tennessee Oncology’s Ashley Todd, Clinical Educator, DNP, RN-BC, OCN®, was published in ONS Voice magazine. Blog Post

Your Microbiome and Cancer Blog Post

Due to Inclement Weather Some Clinics Will Be Open with Delayed Hours, Tuesday, 12/26 Blog Post

We’re Proud to Announce Tennessee Oncology Will Serve Cancer Patients in Cookeville in January. Blog Post

Please join us for our monthly virtual CPAN Advocacy Chat – How 340B in Big Health Systems is Hurting Patients Blog Post

Tennessee Oncology to Present 9 Abstracts at ASCO Quality Care Symposium Blog Post

Managing Early-Stage Melanoma Blog Post

Tennessee Oncology Named One of Nine Oncology Practices Certified Through ASCO Patient-Centered Cancer Care Certification Pilot Blog Post

(Men)ding Lines – Charlie Penley Blog Post

“It’s a great honor to share my friend ‘Hawk’, a fellow Cadet at the Air Force Academy, on this Memorial Day.” – Amy Cox, Nurse Practitioner, Gallatin Clinic Blog Post

“This Memorial Day I remember the American Heroes I met serving in Bosnia, that made the ultimate sacrifice.” – Howard Burris, M.D. Blog Post

HiberCell to Present Posters on Novel Candidates Odetiglucan and HC-7366 at the 2022 Annual American Society of Clinical Oncology Meeting Blog Post

Community Oncology Alliance Launches Oncology Fellows Task Force Blog Post

No Good Deed Goes Unpunished—How PBM Mandates Increase Practice Variability Blog Post

Beyond Immunotherapy: New Targeted Agents for Advanced NSCLC Blog Post

OneOncology’s Arrowsmith Looks Forward to Real-time Dynamics in Clinical Pathways Blog Post

Dr. Stephen Schleicher on Future Advances in Value-Based Care Blog Post

What Is Melanoma? Blog Post

Tennessee Oncology Expands Adoption of OncoSmart™ Oncology Optimization Solution by iClinicalOps Blog Post

Dr Stephen Schleicher on Tennessee Oncology’s Plans Post OCM Blog Post

OneOncology Names Dr. Davey Daniel as Chief Medical Officer Blog Post

Dr Natalie Dickson Discusses Challenges for Tennessee Oncology, Community Oncology Blog Post

Tennessee Oncology Best Tips to Lower Risks of Cancer Blog Post

We are so proud of Dr. Jeff Infante, former Tennessee Oncology physician and key investigator for the Drug Development Unit at Sarah Cannon Research Blog Post

Dr Schleicher, Dr Dickson Discuss New Roles at Tennessee Oncology Blog Post

“The pace at which new therapies are moving brings hope that all blood cancer patients in the future will have great options for treatment.” – William Donnellan, M.D. Blog Post

Tennessee Oncology Appoints Dr. Stephen Schleicher as Chief Medical Officer and Promotes Dr. Natalie Dickson to President and Chief Strategy Officer Blog Post

Tennessee Oncology Re-Certified With Perfect Score for High-Quality Cancer Care from the Largest Oncology Association in United States Blog Post

Provision Cares Proton Therapy Nashville Achieves Accreditation From World’s Leading Radiation Oncology Society Blog Post

H3 Biomedicine Presents Investigational Data Update on H3B-6545 for Treatment of Locally Advanced or Metastatic Estrogen Receptor- positive, HER2-negative Breast Cancer at San Antonio Breast Cancer Symposium Blog Post

Congress must fix the Build Back Better Act to help, not hurt, cancer patients. Blog Post

Tennessee Oncology receives perfect quality score while saving Medicare $5 million during last year of Oncology Care Model Blog Post

Middle Tennessee’s Only Proton Therapy Center Wins National Award For Second Year in a Row Blog Post

Breast Cancer Facebook Live Panel – November 1, 2021 – WATCH NOW! Blog Post

You are Invited to a Breast Cancer Facebook Live Discussion Blog Post

Tennessee Oncology and Blue Cross Blue Shield of Tennessee Launch New Value-Based Care Initiative Blog Post

Dr. Jeff Patton Outlines How Community Oncology Is a Low-Cost, High-Quality Provider Blog Post

How to help your fatigue at home Blog Post

Microsoft’s Iksha Herr to Give Keynote Address at AJMC’s 10th Annual Patient-Centered Oncology Care® Conference Blog Post

New Certification Pilot Focuses on Patient-Centered Cancer Care, Equips Practices with Evidence-based Approach to Value-based Care Delivery Blog Post

Pharmacists are Key to Coordinating Care for Combination Oral, IV Therapies. Blog Post

Dr Daniel: “This Is Exactly How the Accelerated Approval Process Is Supposed to Work” Blog Post

Skin Cancer Can Impact Emotional Well-Being Blog Post

Radiation Therapy in Skin Cancer Blog Post

Interview with Ted Arrowsmith, MD from Tennessee Oncology Blog Post

Woman carries baby for her twin sister who had hysterectomy due to pregnancy-related cancer Blog Post

Ongoing COVID-19 Precautions Blog Post

OneOncology Appoints Two New Board Members Blog Post

Podcast: Dr. F. Anthony Greco Explains How Precision Medicine Has Led to Better Treatments for Cancers of Unknown Origins Blog Post

Providing Cancer Care in the Age of COVID-19 Blog Post

THE BEST MEETING IN COMMUNITY ONCOLOGY IS MORE ACCESSIBLE THAN EVER Blog Post

IMPORTANT REMINDERS: COVID-19 Update 1/4/2021 Blog Post

Expert Insights on Metastatic Breast Cancer Awareness Day: Treating Patients by Subtype Blog Post

OneOncology and Tennessee Oncology Present Twelve Posters at ASCO Quality and Care Symposium Blog Post

IMPORTANT REMINDERS: Tennessee Oncology’s COVID-19 Precaution Requirements Blog Post

Changing Patterns of Care in Multiple Myeloma Blog Post

When is the right time to go on hospice care? Blog Post

Tennessee Oncology Welcomes Two New State-Of-The-Art Clinics in Chattanooga Blog Post

August 1, 2020: Tennessee Oncology’s COVID-19 Precaution Requirements Blog Post

Summer Wellness Blog Post

We can’t let COVID-19 delays lead to a cancer crisis in America | Opinion Blog Post

What every Cancer Patient Should Know about Herbs and Supplements Blog Post

Coronavirus Update – July 1st, 2020 Blog Post

Coronavirus Update – June 1st, 2020 Blog Post

OneOncology Names Jeff Patton, MD as CEO Blog Post

Coronavirus Update 4/30/2020 Blog Post

Supporting Clinical Trials in the Community Oncology Setting Blog Post

Experts in Oncology Review What COVID-19 Has Taught Them Blog Post

How I Practice Now: Connecting With Patients at Tennessee Oncology Blog Post

OneOncology and Tennessee Oncology Partnership Fuels Expansion in Chattanooga with Addition of University Oncology Hematology Associates Blog Post

A Message To All Tennessee Oncology Patients Blog Post

NCODA’s Positive Quality Intervention in Action Blog Post

COA Conference Going Virtual and Bigger than Ever! Blog Post

The One Must-Attend Community Oncology Event of the Year Blog Post

OneCommunity Tumor Boards Offer Virtual, Real-Time Expert Consensus Blog Post

Join Us at the Best-In-Class Oncology Conference: COA 2020 Blog Post

Year Past, Year Forward. Thanks To You, We’re Doing Great. Blog Post

OneOncology Expands to New England with Eastern Connecticut Hematology and Oncology Blog Post

Achieving Success in Value-Based Payment Models Through Pathway Adherence Blog Post

The Oncology Care Model Value Proposition Blog Post

OneOncology Study Reveals Important Insights for Value-Based Care Blog Post

How to Be a Friend to Someone With Cancer Blog Post

Stephen Schleicher, MD, MBA featured in AJMCtv October 2019 Blog Post

What Incentivized These Oncology Clinics To Embrace Biosimilars? Blog Post

Congratulations to our Nashville Business Journal Best Doctors for 2019 Blog Post

The Role of the Specialty Pharmacist in Transitioning Patients from Cancer Crisis Care to the Community Blog Post

$4 Million Development To Boost Economic Growth In North Georgia Blog Post

What does patient-centric care look like? Blog Post

Tennessee Oncology Chosen To Present Six Posters at the American Society of Clinical Oncology (ASCO) Annual Quality of Care Symposium in San Diego, California. Blog Post

There’s A Battle Brewing Over Who Gets To Sell Chemo Pills For Cancer Treatment Blog Post

What Should You Ask Your Health Care Team About Prostate Cancer? Blog Post

Streamlining Patient-Reported Outcomes to Boost Value-Based Care Blog Post

Signs and Symptoms of Gastrointestinal Stromal Tumors Blog Post

The Future of Healthcare: “Healthcare is far too reactive” with Dr. Jeff Patton of OneOncology and Christina D. Warner Blog Post

Population of US Cancer Survivors Grows to Nearly 17 Million Blog Post

New study estimates preventable cancer burden linked to poor diet in the US Blog Post

How Family History Affects Prostate Cancer Risk Blog Post

How to Spot Skin Cancer Blog Post

What Is Cancer Immunotherapy? Blog Post

Exercises After Breast Cancer Surgery Blog Post

The effect of guideline-concordant novel therapy use on meeting cost targets in OCM: Results from a large community oncology network. Blog Post

OneOncology Announces the Launch of Comprehensive Cancer Center in Southern Arizona Blog Post

Phase 2 Trial Examines Gene-Expression Profiling for Cancer of Unknown Primary Site Blog Post

Artificial Intelligence Pilots in Community Oncology Yield Promising Results Blog Post

Lee Schwartzberg tells us how three practices banded together to adapt to today’s cancer care and data revolution Blog Post

Winter Exits. Spring Arrives. Truths We Trust. Blog Post

Job Well Done. Blog Post

OneOncology Uses Healthcare Data Analytics To Share Best Practices Blog Post

2019 Is Primed For A Great Start. Take A Leading Role. Blog Post

An Avalanche of Christmas Kindness Blog Post

Radiation therapy services return to North Georgia Blog Post

At Tennessee Oncology, Community Oncology is a Passion. Blog Post

Trophy State. Valued Input. Optimism. Teamwork. Blog Post

Data analytics, telemedicine aid in cancer survivorship care Blog Post

Why and When To Get a Mammogram feat. Dr. Erika Hamilton of Tennessee Oncology – WKRN Nashville News 2 Blog Post

Community providers form independent cancer care network Blog Post

Meet Your ASCO President-Elect, Dr. Howard A. “Skip” Burris Blog Post

New cancer care company lands $200M from former Emdeon owner Blog Post

Equity firm invests $200 million to launch Nashville oncology company Blog Post

General Atlantic Takes Majority Stake in OneOncology, a Startup for Running Cancer-Doctor Practices Blog Post

Sarah Cannon Promotes William Donnellan, MD, to Director, Leukemia/Myelodysplastic Syndrome Research Blog Post

Family and Friends. Independence. Optimism. Our Future. Blog Post

Easy Monthly Breast Exam at Home – Brooke R. Daniel, M.D. Blog Post

Next Generation Sequencing – Edward Arrowsmith, M.D. Blog Post

Tennessee Oncology St.Thomas West’s Dr. Kent Shih and Staff, Country Music Artist Jackie Lee, Rolling Stone Magazine and an Evening at the Opry Blog Post

Memorial Day is a special day of remembrance and honor. Blog Post

Our Goal Is to Make Every Patient… See That Here, Caring for Cancer Patients Is a Privilege Blog Post

Partnership To Provide “Leading Edge” Radiation Oncology Services Blog Post

Longer Days. Shorter Nights. We Serve Alongside Each Other. Blog Post

It’s 2018. Finding Ways to Improve and Making it Another Wonderful Year. Blog Post

Due to weather, the following clinics will be closed today, January 17: Blog Post

Due to weather, the following clinics will be closed today, January 16: Blog Post

Please Read If You Are Receiving Treatments At Our Tullahoma Clinic- Blog Post

POST-ASH CLL PATIENT AND CAREGIVER EDUCATIONAL FORUM Blog Post

2017, Christmas And A Magnificent New Year Blog Post

My Path to Oncology Blog Post

A Few Basic Tips for Caregivers Blog Post

Navigating Thanksgiving Events as a Cancer Patient Blog Post

Tobacco is Still the Number One Cause of Lung Cancer Blog Post

Facts About Men’s Breast Cancer Blog Post

Does site-of-care for oncology infusion therapy influence treatment patterns, cost, and quality in the United States? Blog Post

Diet & Exercise During Breast Cancer Treatment Blog Post

Breast Cancer Signs & Symptoms to Know Blog Post

Inch By Inch, Life’s A Cinch. Yard By Yard, Life Is Hard. And Other Things. Blog Post

Volunteerism in Oncology Blog Post

Advances In Breast Cancer Blog Post

Immunotherapy is Changing the Lives of Melanoma Patients Blog Post

Promising New Therapies in Stomach Cancer Treatment Blog Post

Lung Cancer Causes More Deaths In The United States Than Any Other Type Of Cancer Blog Post

Long-Term and Late Effects of Treatment in Cancer Survivors Blog Post

The Tennessee Oncology Network Delivers The Most Advanced Care In Every Community We Serve. Blog Post

What’s Trending In The Next 3-5 Years In Cancer Care Blog Post

Promising Immunotherapy For Cancer Patients Blog Post

Breakthroughs in Therapies and Treatments For Blood Cancers Blog Post

Smoking, Radon Gas, Lung Cancer And A Quick Quiz Blog Post

Parenting Tips for Parents That Are Also Cancer Patients Blog Post

Rapid infusion of ofatumumab appears safe and reduces infusion related reactions in patients with relapsed/refractory Chronic Lymphocytic Leukemia Blog Post

Summer Is Scorching But The Lifestyle Is Hard To Beat. Leading Practices Embrace Change Because Our Patients Deserve Our Best. Blog Post

Congress must fix 340B to save it from hospital greed. Blog Post

Medical Assistant Hiring Event Blog Post

Tennessee Oncology Group Finds Growth Bonanza in Clinical Trials Blog Post

Good advice on sunscreens and tanning beds. Blog Post

Even With Cancer Treatment, It’s Still Summer- Find Some Fun. Blog Post

Preds Rule The Month. Picnics Rule The Day. Survivors Rule. Blog Post

Small Acts Of Kindness For Cancer Patients Blog Post

June Is The Month Designated For Cancer Survivors Blog Post

The Tennessee Cancer Consortium invites you and a guest to attend Thriving Together: Living Beyond Metastatic Breast Cancer Blog Post

May Is One Fine Month. Nurse Respect. Clinical Trials Close To Home. Honoring Memorial Day. Blog Post

The Oncology Nursing Society 2017 Congress Employer Recognition Awards Blog Post

National Women’s Health Week – May 14 – 20, 2017– When Should You Begin Some Common Cancer Screenings? Blog Post

Would You Like To Support Cancer Research And Do Something Good For Your Health? This Blog’s For You. Blog Post

May Is Skin Cancer Prevention and Awareness Month. Know The Good News And How To Protect Yourself From The Bad. Blog Post

Trusted Truth Tellers. Spring And Time. OncoEMR And Shout Out To The Teams And Providers. Blog Post

Danielle’s Story Blog Post

Electronic Medical Records, Practice Will Make Perfect- Patience and Diligence Will Get Us There Blog Post

April Is National Minority Health Month. Minority Populations Often Experience Higher Rates Of Disease. Blog Post

The Benefits of Cooperation Between Palliative and Cancer Specialists Blog Post

Healthy Eating Habits are Important for Cancer Patients Blog Post

3 Things To Know About Colorectal Cancer Blog Post

Tennessee Oncology’s Park Pharmacy Improves Efficiencies In the Delivery Of Cancer Drugs Blog Post

The Value Of Exercise Only Grows Blog Post

Keep your mind clear and uncluttered to keep your energy level high and your focus on what matters most Blog Post

Patient letter to An L. Tran, M.D. in Cleveland, TN Blog Post

Tennessee Oncology Receives The Oncology Nurse Society (ONS) 2017 Employer Recognition Award Blog Post

Tennessee Oncology Continually Improves Patient Experience. Pilot Study Reduces ER Visits In Patients Receiving IV Chemo. Blog Post

Pursuit of Perfection Blog Post

Good questions to ask if your physician has recommended chemotherapy. Blog Post

Good news in the battle against cancer. Blog Post

Tennessee Oncology Initiatives Reduces Response Time For Symptom Management Calls Blog Post

Dr. Mainuddin helps efforts in Tullahoma for 21st annual Karing for Kids campaign. Blog Post

Meet the Cleveland Doctor Making House Calls and Touching Lives Blog Post

Breast Cancer Blog Post

Dr. Hamilton on breast and gynecologic cancers Blog Post

Racial disparities receding for women with breast cancer Blog Post

Local breast cancer survivors take to the runway for, “Heroes in Heels Fashion Show at the Factory in Franklin” Blog Post

September is Thyroid Cancer Awareness Month Blog Post

Mayo Clinic survey finds cancer is most concerning health condition Blog Post

Dr. Jeff Patton, CEO shares and comments on a recent Wall Street Journal article. Blog Post

Tennessee Oncology purchases Charlotte Ave. site Blog Post

Medicare changes would jeopardize cancer patients Blog Post

May is Melanoma Month Blog Post

Oncology Care Model (OCM) Blog Post

Growth plan: Adding to Tennessee Oncology’s ranks Blog Post

Esophageal Cancer Blog Post

Tennessee Oncology selected for Oncology Care Model Blog Post

Tennessee Oncology’s Dr. Nancy Peacock on self breast exams. Blog Post

Colorectal Cancer Blog Post

Nashville Free To Breath run/walk Blog Post

Tennessee Oncology’s Dr. Dianna Shipley on Talk of the Town’s Be Your Best Blog Post

Dr. Johnetta Blakely appears on More at Midday. Blog Post

Tennessee Oncology’s Dr. Charlie Penley on Talk of the Town’s Be Your Best. Blog Post

Tennessee Oncology’s Dr. Matt Joseph on More at Midday Blog Post

Be Your Best with Talk of the Town – Dr. Anthony Meluch Blog Post

Genmab Announces U.S. FDA Approval of Arzerra® (ofatumumab) as Extended Treatment for Recurrent or Progressive CLL Blog Post

After Cancer Treatment Blog Post

Cervical Cancer Awareness Blog Post

FDA Approves Expanded Indication for Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Advanced Melanoma Blog Post

Cancer and the Holidays: Answers to Common Questions Blog Post

FDA allows marketing of cooling cap to reduce hair loss during chemotherapy Blog Post

Important holiday safety advice for cancer patients and families Blog Post

FDA approves Empliciti, a new immune-stimulating therapy to treat multiple myeloma Blog Post

FDA approves Portrazza to treat advanced squamous non-small cell lung cancer Blog Post

FDA approves Darzalex for patients with previously treated multiple myeloma Blog Post

TENNESSEE ONCOLOGY CONTINUES TO GROW NETWORK WITH ADDITION OF DR. JEREMY MCDUFFIE Blog Post

A Breakthrough for Men with Advanced Prostate Cancer Blog Post

Tips for supporting your friends and loved ones Blog Post

Gregory Sutton Joins Tennessee Oncology Blog Post

PathGroup Launches New SmartGenomics™ Cancer-Specific Testing Blog Post

Harnessing the Power of the Immune System to Fight Cancer Blog Post

June is National Cancer Survivor Month Blog Post

Latest advances on cancer research Blog Post

Her patients become like family Blog Post

The Push to Palliate Cancer Symptoms Blog Post

Tennessee Oncology Moves To New Clinic In Downtown Cleveland Blog Post

BlueCross, Tennessee Oncology Pilot Digital Tools To Improve Care, Experience For Cancer Patients Blog Post

Julie Means-Powell joins Tennessee Oncology Blog Post

See our own Dr Meadows discuss palliative care. Blog Post

Advances in Lung Cancer Diagnosis May Hold Key to Fighting the Disease Blog Post

Immunotherapy interview with Dr. Kent Shih Blog Post

October is Breast Cancer Awareness Month Blog Post

Lung cancer causes more deaths in the United States that any other type of cancer Blog Post

Dr. David Spigel, Tennessee Oncology physician, on FOXNews Blog Post

Seven Years at Tennessee Oncology Blog Post

How Tennessee Oncology is getting patients to say how they really feel Blog Post

Hope strong weapon in fight against colorectal cancer Blog Post

Tennessee Oncology Welcomes Dr. Stephen Golder Blog Post

Tennessee Oncology Completes Merger With Chattanooga Oncology And Hematology Associates Blog Post

Opinion – Affordable Care Act Blog Post

Tennessee Oncology recognized for service Blog Post

Regular screenings key to cervical wellness Blog Post

Mammograms are Key to breast cancer awareness Blog Post

Tennessee Oncology Fights Cancer Blog Post

Affordable Care Act: It’s All in the Details … and There Are No Details Blog Post

Scaling Cancer Care Blog Post

Doctors say cancer shouldn’t always be called ‘cancer’ Blog Post

Tennessee Oncology first in state to offer oral breast cancer treatment Blog Post

Testicular Cancer: Highly Curable Malignancy in Men Blog Post

Nancy Peacock, MD is chosen one of Nashville Medical News’ 2013 Women to Watch Blog Post

Dr. Charles Penley interviewed by the Wall Street Journal Blog Post

The Changing Landscape of Cancer Treatment Blog Post

Dr. Jeff Patton wins CEO recognition Blog Post

Hematology Page

Mesothelioma Blog Post

Melanoma Blog Post

News Page

Disclaimer Page

Financial Page

Resources Page

Therapies Page

Results Page

Thankful Blog Post

Sonidegib Blog Post